Skip to content

Prospective Trial of the Effect of Preoperative Forced-air Warming on Perioperative Body Temperature Following Neuraxial Anesthesia in Total Hip Arthroplasty Patients

Prospective Randomized Control Trial of the Effect of Preoperative Forced-air Warming on Perioperative Body Temperature Following Neuraxial Anesthesia in Total Hip Arthroplasty Patients

Status
Terminated
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01626690
Enrollment
100
Registered
2012-06-25
Start date
2012-05-31
Completion date
2014-12-31
Last updated
2016-08-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perioperative Hypothermia

Brief summary

The purpose of this study is to determine if placement of a forced-air warming device prior to institution of regional anesthesia improves perioperative temperature control in patients undergoing total hip arthroplasty.

Interventions

DEVICEBair-Paws Warming Device

Bair-Paws device to be applied to patient and used for perioperative (including preoperative) warming.

DEVICEBair-Hugger Warming Device

Bair-Hugger device to be applied to patient and used for intraoperative warming (current standard of care at our institution).

Sponsors

University of Wisconsin, Madison
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
55 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* patients undergoing total hip arthroplasty under neuraxial anesthesia, * age 55-85, * BMI 18-40

Exclusion criteria

* allergy to local anesthetics, * patients electing to have general anesthesia for their total hip arthroplasty, * pregnancy, * prisoners, * patients unable to give informed consent, * English as a second language, * active infectious or febrile illness (measured temperature \> 37.5 degrees Celsius).

Design outcomes

Primary

MeasureTime frameDescription
Patient Temperature at the Time of Incision as Measured by SpotOn (3M) Temperature Monitoring System..The treatment period starts with the patient consenting to the study and application of preoperative forced-air warming device and ends when the patient leaves the PACU (average 4-8 hours following enrollment).Temporal artery temperature readings (in degrees celsius) will be obtained at the time of incision and every 30 minutes while in the OR.

Secondary

MeasureTime frameDescription
Patient Temperature 30 Minutes Following Incision as Measured by SpotOn (3M) Temperature Monitoring System.The treatment period starts with the patient consenting to the study and application of preoperative forced-air warming device and ends when the patient leaves the PACU (average 4-8 hours following enrollment).
Patient Temperature on Arrival to Recovery Room as Measured by SpotOn (3M) Temperature Monitoring System.The treatment period starts with the patient consenting to the study and application of preoperative forced-air warming device and ends when the patient leaves the PACU (average 4-8 hours following enrollment).
Incidence of Postoperative Shivering in Recovery Room.The treatment period starts with the patient consenting to the study and application of preoperative forced-air warming device and ends when the patient leaves the PACU (average 4-8 hours following enrollment).
Patient Temperature Prior to Entering OR as Measured by SpotOn (3M) Temperature Monitoring System.The treatment period starts with the patient consenting to the study and application of preoperative forced-air warming device and ends when the patient leaves the PACU (average 4-8 hours following enrollment).
Incidence of Perioperative Cardiac Events.The treatment period starts with the patient consenting to the study and application of preoperative forced-air warming device and ends when the patient leaves the PACU (average 4-8 hours following enrollment).Incidence of perioperative arrhythmias or myocardial ischemia.
Temporal Artery Verus SpotOn (3M) Temperature Readings.The treatment period starts with the patient consenting to the study and application of preoperative forced-air warming device and ends when the patient leaves the PACU (average 4-8 hours following enrollment).Temperature with temporal artery thermometer and SpotOn temperature monitoring device (3M) at time of incision.
Intraoperative Blood Loss.The treatment period starts with the patient consenting to the study and application of preoperative forced-air warming device and ends when the patient leaves the PACU (average 4-8 hours following enrollment).Intraoperative blood loss in mL's.

Countries

United States

Participant flow

Participants by arm

ArmCount
Pre-Warming
Bair-Paws Warming Device: Bair-Paws device to be applied to patient and used for perioperative (including preoperative) warming.
47
Control
Bair-Hugger Warming Device: Bair-Hugger device to be applied to patient and used for intraoperative warming (current standard of care at our institution).
51
Total98

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyAdverse Event10
Overall StudyProtocol Violation10

Baseline characteristics

CharacteristicPre-WarmingControlTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
26 Participants28 Participants54 Participants
Age, Categorical
Between 18 and 65 years
21 Participants23 Participants44 Participants
Age, Continuous66.1 years
STANDARD_DEVIATION 6.37
66.5 years
STANDARD_DEVIATION 7.41
66.3 years
STANDARD_DEVIATION 6.9
Baseline Temperature36.6 Degrees Celisius
STANDARD_DEVIATION 0.4
36.7 Degrees Celisius
STANDARD_DEVIATION 0.37
36.6 Degrees Celisius
STANDARD_DEVIATION 0.39
Region of Enrollment
United States
47 participants51 participants98 participants
Sex: Female, Male
Female
27 Participants24 Participants51 Participants
Sex: Female, Male
Male
20 Participants27 Participants47 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 470 / 51
serious
Total, serious adverse events
0 / 470 / 51

Outcome results

Primary

Patient Temperature at the Time of Incision as Measured by SpotOn (3M) Temperature Monitoring System..

Temporal artery temperature readings (in degrees celsius) will be obtained at the time of incision and every 30 minutes while in the OR.

Time frame: The treatment period starts with the patient consenting to the study and application of preoperative forced-air warming device and ends when the patient leaves the PACU (average 4-8 hours following enrollment).

ArmMeasureValue (MEAN)Dispersion
Pre-WarmingPatient Temperature at the Time of Incision as Measured by SpotOn (3M) Temperature Monitoring System..35.7 Degrees CelsiusStandard Deviation 0.47
ControlPatient Temperature at the Time of Incision as Measured by SpotOn (3M) Temperature Monitoring System..35.4 Degrees CelsiusStandard Deviation 0.49
Secondary

Incidence of Perioperative Cardiac Events.

Incidence of perioperative arrhythmias or myocardial ischemia.

Time frame: The treatment period starts with the patient consenting to the study and application of preoperative forced-air warming device and ends when the patient leaves the PACU (average 4-8 hours following enrollment).

ArmMeasureValue (NUMBER)
Pre-WarmingIncidence of Perioperative Cardiac Events.1 Patients
ControlIncidence of Perioperative Cardiac Events.0 Patients
Secondary

Incidence of Postoperative Shivering in Recovery Room.

Time frame: The treatment period starts with the patient consenting to the study and application of preoperative forced-air warming device and ends when the patient leaves the PACU (average 4-8 hours following enrollment).

ArmMeasureValue (NUMBER)
Pre-WarmingIncidence of Postoperative Shivering in Recovery Room.1 Number of patients reporting shivering
ControlIncidence of Postoperative Shivering in Recovery Room.14 Number of patients reporting shivering
Secondary

Intraoperative Blood Loss.

Intraoperative blood loss in mL's.

Time frame: The treatment period starts with the patient consenting to the study and application of preoperative forced-air warming device and ends when the patient leaves the PACU (average 4-8 hours following enrollment).

ArmMeasureValue (MEAN)Dispersion
Pre-WarmingIntraoperative Blood Loss.263 mLStandard Deviation 109
ControlIntraoperative Blood Loss.307 mLStandard Deviation 116
Secondary

Patient Temperature 30 Minutes Following Incision as Measured by SpotOn (3M) Temperature Monitoring System.

Time frame: The treatment period starts with the patient consenting to the study and application of preoperative forced-air warming device and ends when the patient leaves the PACU (average 4-8 hours following enrollment).

ArmMeasureValue (MEAN)Dispersion
Pre-WarmingPatient Temperature 30 Minutes Following Incision as Measured by SpotOn (3M) Temperature Monitoring System.35.7 Degrees CelsiusStandard Deviation 0.4
ControlPatient Temperature 30 Minutes Following Incision as Measured by SpotOn (3M) Temperature Monitoring System.35.4 Degrees CelsiusStandard Deviation 0.4
Secondary

Patient Temperature on Arrival to Recovery Room as Measured by SpotOn (3M) Temperature Monitoring System.

Time frame: The treatment period starts with the patient consenting to the study and application of preoperative forced-air warming device and ends when the patient leaves the PACU (average 4-8 hours following enrollment).

ArmMeasureValue (MEAN)Dispersion
Pre-WarmingPatient Temperature on Arrival to Recovery Room as Measured by SpotOn (3M) Temperature Monitoring System.35.4 Degrees CelsiusStandard Deviation 0.8
ControlPatient Temperature on Arrival to Recovery Room as Measured by SpotOn (3M) Temperature Monitoring System.35.1 Degrees CelsiusStandard Deviation 0.6
Secondary

Patient Temperature Prior to Entering OR as Measured by SpotOn (3M) Temperature Monitoring System.

Time frame: The treatment period starts with the patient consenting to the study and application of preoperative forced-air warming device and ends when the patient leaves the PACU (average 4-8 hours following enrollment).

ArmMeasureValue (MEAN)Dispersion
Pre-WarmingPatient Temperature Prior to Entering OR as Measured by SpotOn (3M) Temperature Monitoring System.36.7 Degrees CelsiusStandard Deviation 0.4
ControlPatient Temperature Prior to Entering OR as Measured by SpotOn (3M) Temperature Monitoring System.36.6 Degrees CelsiusStandard Deviation 0.4
Secondary

Temporal Artery Verus SpotOn (3M) Temperature Readings.

Temperature with temporal artery thermometer and SpotOn temperature monitoring device (3M) at time of incision.

Time frame: The treatment period starts with the patient consenting to the study and application of preoperative forced-air warming device and ends when the patient leaves the PACU (average 4-8 hours following enrollment).

ArmMeasureValue (MEAN)Dispersion
Pre-WarmingTemporal Artery Verus SpotOn (3M) Temperature Readings.36.5 Degrees CelsiusStandard Deviation 0.5
ControlTemporal Artery Verus SpotOn (3M) Temperature Readings.36.5 Degrees CelsiusStandard Deviation 0.5

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026